Alliance Pharma (LON:APH) Shares Cross Above 200-Day Moving Average – Time to Sell?

Alliance Pharma plc (LON:APH) shares crossed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of GBX 52.26 ($0.67) and traded as high as GBX 64.50 ($0.83). Alliance Pharma shares last traded at GBX 64.20 ($0.83), with a volume of 476,889 shares changing hands.

Analyst Ratings Changes

Separately, Berenberg Bank downgraded Alliance Pharma to a “hold” rating and cut their price target for the company from GBX 7,000 ($90.30) to GBX 6,250 ($80.62) in a report on Wednesday, January 29th.

Alliance Pharma Stock Up 0.2 %

The stock has a market cap of £348.29 million, a price-to-earnings ratio of -10.37, a price-to-earnings-growth ratio of 1.04 and a beta of 0.67. The firm’s 50-day moving average is GBX 62.51 and its 200 day moving average is GBX 52.43. The company has a debt-to-equity ratio of 46.27, a current ratio of 2.93 and a quick ratio of 1.42.

About Alliance Pharma

Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. The company also offers medicines, medical devices, food supplements, and cosmetics.